Endo International (ENDP) Tops Q3 EPS by 38c, Updates Guidance

Endo International (NASDAQ: ENDP) reported Q3 EPS of $0.52, $0.38 better than the analyst estimate of $0.14. Revenue for the quarter came in at $635 million versus the consensus estimate of $547.8 million.

GUIDANCE:

Endo International sees FY2020 EPS of $2.50-$2.55, versus the consensus of $2.14. Endo International sees FY2020 revenue of $2.75-2.8 billion, versus the consensus of $2.7 billion.

For earnings history and earnings-related data on Endo International (ENDP) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Infleqtion raises Q2 revenue to $13.5M after contract restatement
• INVO Fertility (IVF) Tops Q2 EPS by 105c